Max Payne Remakes Energy Forward as Treatment Reviews Elevated Income

Max Payne and Management developer Treatment Leisure has launched its monetary report for the primary half of the 2025 fiscal 12 months, and it incorporates some encouraging information about Management 2 and the forthcoming Max Payne remakes.

Per Treatment’s report, the Max Payne remakes, which nonetheless do not have a launch window, have now entered “the total manufacturing stage”, having entered the “manufacturing readiness stage” again in October final 12 months. This implies improvement on the remakes is progressing fairly easily.

The report additionally presents an replace on Management 2, which was first introduced in November 2022. The upcoming sequel has entered the aforementioned “manufacturing readiness stage”, in response to Treatment, which suggests we will doubtless count on full manufacturing to ramp up a number of months from now.

Moreover, in case you’re searching for an replace on Treatment’s Management spinoff Codename Condor, which can or might not find yourself being referred to as FBC: Firebreak, that is additionally in full manufacturing, in response to Treatment.

All of this data comes from a monetary report that additionally sees Treatment’s income growing by 33.7% year-over-year, though earnings are down by round 10%, so it isn’t a wholly rosy image for the Finnish studio.

Sadly, it seems like issues nonetheless aren’t trying up for horror sequel Alan Wake 2, both, as the sport has but to show a revenue ten months after its launch. Regardless of that, Treatment CEO Tero Virtala says the sport has “recouped most of its improvement and advertising bills” on the time of the report’s publication.

Virtala additionally says that the cancellation of Tencent collab Codename Kestrel again in Might has given the studio “elevated focus and higher improvement synergies”, in addition to permitting it to “transfer skilled builders into different sport tasks”.

So, what’s subsequent for Treatment? Proper now, the studio has “two video games in full manufacturing” (that is the Max Payne remakes and Condor, so it seems like Treatment is counting these remakes as one challenge) and one “within the manufacturing readiness stage” (i.e. Management 2).

The studio additionally says that because it acquired the rights to the Management franchise from 505 Video games, it is in a position to “select find out how to deliver [its] future video games to the market”, which includes “weighing self-publishing” and “totally different accomplice publishing alternatives”.

We’ll have to attend and see what occurs subsequent, however we’ll doubtless get extra data on the Max Payne remakes, in addition to Management 2 and Condor, within the coming months. Keep tuned for extra.